Abeona Therapeutics (ABEO) Current Leases (2019 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Current Leases of $1.3 million for Q1 2026, up 107.5% year-over-year from $613000.0 in Q1 2025, and up 47.22% quarter-over-quarter from $864000.0 in Q4 2025.
Abeona Therapeutics (ABEO) Current Leases (2019 - 2026) Analysis & Trends
Abeona Therapeutics' Current Leases history runs 8 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Current Leases rose 107.5% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 107.5% YoY), while the FY2025 annual figure was $864000.0, up 4.98% from the prior year.
- Current Leases for Q1 2026 stood at $1.3 million, up from $864000.0 in the prior quarter.
- The five-year high for Current Leases was $1.8 million in Q1 2022, with the low at $102000.0 in Q3 2025.
- The 5-year median for Current Leases is $1.3 million (2026), against an average of $1.3 million.
- The sharpest annual moves came in 2025 and 2026: Current Leases sank 90.35% in 2025, then jumped 107.5% in 2026.
- Abeona Therapeutics' Current Leases stood at $1.8 million in 2022, then slumped by 43.71% to $998000.0 in 2023, then retreated by 17.54% to $823000.0 in 2024, then climbed by 4.98% to $864000.0 in 2025, then surged by 47.22% to $1.3 million in 2026.
- Business Quant data shows ABEO's Current Leases at $1.3 million in Q1 2026, $864000.0 in Q4 2025, and $102000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | 1.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.28 Mn |
| Mar 31, 2026 | 1.27 Mn |
| Dec 31, 2025 | 864,000.00 |
| Sep 30, 2025 | 102,000.00 |
| Jun 30, 2025 | 537,000.00 |
| Mar 31, 2025 | 613,000.00 |
| Dec 31, 2024 | 823,000.00 |
| Sep 30, 2024 | 1.06 Mn |
| Jun 30, 2024 | 1.79 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 998,000.00 |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 1.81 Mn |
| Jun 30, 2022 | 1.80 Mn |
| Mar 31, 2022 | 1.82 Mn |
| Dec 31, 2021 | 1.82 Mn |
| Sep 30, 2021 | 1.72 Mn |